Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jun;30(6):1446-8.
doi: 10.1038/leu.2015.338. Epub 2015 Dec 9.

Whole-body diffusion-weighted MRI: a new gold standard for assessing disease burden in patients with multiple myeloma?

Affiliations

Whole-body diffusion-weighted MRI: a new gold standard for assessing disease burden in patients with multiple myeloma?

C Pawlyn et al. Leukemia. 2016 Jun.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
WB-DWI improves detection of diffuse marrow infiltration compared with FDG PET–CT and detects trephine sampling error. WB-DWI b900 maximum intensity projection image (a) and FDG PET–CT (b) in the same patient. WB-DWI demonstrates diffuse infiltration of the bone marrow; FDG PET–CT shows no evidence of disease. WB-DWI b900 maximum intensity projection image (c) demonstrates multifocal disease (examples shown by arrows). Axial b900 image (superimposed) shows the trephine tract (arrow), which does not sample a focal lesion.

References

    1. Dimopoulos MA, Hillengass J, Usmani S, Zamagni E, Lentzsch S, Davies FE et al. Role of magnetic resonance imaging in the management of patients with multiple myeloma: a consensus statement. J Clin Oncol 2015; 33: 657–664. - PubMed
    1. Merz M, Hielscher T, Wagner B, Sauer S, Shah S, Raab MS et al. Predictive value of longitudinal whole-body magnetic resonance imaging in patients with smoldering multiple myeloma. Leukemia 2014; 28: 1902–1908. - PubMed
    1. Mai EK, Hielscher T, Kloth JK, Merz M, Shah S, Raab MS et al. A magnetic resonance imaging-based prognostic scoring system to predict outcome in transplant-eligible patients with multiple myeloma. Haematologica 2015; 100: 818–825. - PMC - PubMed
    1. Zamagni E, Patriarca F, Nanni C, Zannetti B, Englaro E, Pezzi A et al. Prognostic relevance of 18-F FDG PET/CT in newly diagnosed multiple myeloma patients treated with up-front autologous transplantation. Blood 2011; 118: 5989–5995. - PubMed
    1. Zamagni E, Nanni C, Patriarca F, Englaro E, Castellucci P, Geatti O et al. A prospective comparison of 18F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in the assessment of bone disease in newly diagnosed multiple myeloma. Haematologica 2007; 92: 50–55. - PubMed

Publication types